Cite
Variability in the efficacy of the IL1 receptor antagonist anakinra for treating Erdheim-Chester disease
MLA
Cohen-Aubart, Fleur, et al. “Variability in the Efficacy of the IL1 Receptor Antagonist Anakinra for Treating Erdheim-Chester Disease.” Blood, vol. 127, no. 11, Mar. 2016, pp. 1509–12. EBSCOhost, https://doi.org/10.1182/blood-2015-09-672667.
APA
Cohen-Aubart, F., Maksud, P., Saadoun, D., Drier, A., Charlotte, F., Cluzel, P., Amoura, Z., & Haroche, J. (2016). Variability in the efficacy of the IL1 receptor antagonist anakinra for treating Erdheim-Chester disease. Blood, 127(11), 1509–1512. https://doi.org/10.1182/blood-2015-09-672667
Chicago
Cohen-Aubart, Fleur, Philippe Maksud, David Saadoun, Aurélie Drier, Frédéric Charlotte, Philippe Cluzel, Zahir Amoura, and Julien Haroche. 2016. “Variability in the Efficacy of the IL1 Receptor Antagonist Anakinra for Treating Erdheim-Chester Disease.” Blood 127 (11): 1509–12. doi:10.1182/blood-2015-09-672667.